Cargando…
Mfn2-mediated mitochondrial fusion alleviates doxorubicin-induced cardiotoxicity with enhancing its anticancer activity through metabolic switch
Imbalanced mitochondrial dynamics including inhibited mitochondrial fusion is associated with cardiac dysfunction as well as tumorigenesis. This study sought to explore the effects of promoting mitochondrial fusion on doxorubicin(Dox)-induced cardiotoxicity and its antitumor efficacy, with a focus o...
Autores principales: | Ding, Mingge, Shi, Rui, Cheng, Shuli, Li, Man, De, Dema, Liu, Chaoyang, Gu, Xiaoming, Li, Juan, Zhang, Shumiao, Jia, Min, Fan, Rong, Pei, Jianming, Fu, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006862/ https://www.ncbi.nlm.nih.gov/pubmed/35413642 http://dx.doi.org/10.1016/j.redox.2022.102311 |
Ejemplares similares
-
Corrigendum to “Mfn2-mediated mitochondrial fusion alleviates doxorubicin-induced cardiotoxicity with enhancing its anticancer activity through metabolic switch” [Redox Biol. 52 (2022) 1–16/102311]
por: Ding, Mingge, et al.
Publicado: (2022) -
Paeonol protects against doxorubicin-induced cardiotoxicity by promoting Mfn2-mediated mitochondrial fusion through activating the PKCε-Stat3 pathway
por: Ding, Mingge, et al.
Publicado: (2022) -
Trophoblast Stem-Cell-Derived Exosomes Alleviate Cardiotoxicity of Doxorubicin via Improving Mfn2-Mediated Mitochondrial Fusion
por: Duan, Junfeng, et al.
Publicado: (2023) -
Paeonol promotes Opa1-mediated mitochondrial fusion via activating the CK2α-Stat3 pathway in diabetic cardiomyopathy
por: Liu, Chaoyang, et al.
Publicado: (2021) -
Flavaglines Alleviate Doxorubicin Cardiotoxicity: Implication of Hsp27
por: Bernard, Yohann, et al.
Publicado: (2011)